CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended 9 Months Ended 86 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Revenues $ 0 $ 0 $ 0 $ 0 $ 0
Costs and expenses:          
General and administrative, including $356,486 and $53,329 of stock-based expense for the three months ended September 30, 2012 and 2011, respectively, $$671,110 and $93,857 of stock-based expense for the nine months ended September 30, 2012 and 2011, respectively, and $$3,128,531 of stock-based expense for the period from August 9, 2005 (inception) to September 30, 2012 (cumulative) 444,499 134,852 945,572 348,050 5,084,898
Depreciation 0 0 0 0 1,909
Research and development, including $293,450 and $-0- of stock-based expense for the three months ended September 30, 2012 and 2011, respectively, $293,450 and $982 of stock-based expense for the nine months ended September 30, 2012 and 2011, respectively, and $758,484 of stock-based expense for the period from August 9, 2005 (inception) to September 30, 2012 (cumulative), respectively. 393,670 364,389 884,485 850,043 4,442,134
Reverse merger costs 0 0 0 0 50,000
Total costs and expenses 838,169 499,241 1,830,057 1,198,093 9,578,941
Loss from operations (838,169) (499,241) (1,830,057) (1,198,093) (9,578,941)
Interest income 1 27 7 111 27,434
Interest expense 0 0 0 0 (2,469)
Fair value of warrant extensions (1,139,592) (199,839) (1,139,592) (199,839) (1,339,431)
Fair value of warrant discount 0 0 (334,024) 0 (334,024)
Liquidated damages under registration rights agreement 0 0 0 0 (74,000)
Net loss $ (1,977,760) $ (699,053) $ (3,303,666) $ (1,397,821) $ (11,301,431)
Net loss per common share - basic and diluted (in dollars per share) $ (0.05) $ (0.02) $ (0.09) $ (0.04)  
Weighted average common shares outstanding - basic and diluted (in shares) 41,558,409 35,259,142 38,113,757 35,139,166